CN115006265A - 一种分离式凝胶面膜 - Google Patents
一种分离式凝胶面膜 Download PDFInfo
- Publication number
- CN115006265A CN115006265A CN202210706954.9A CN202210706954A CN115006265A CN 115006265 A CN115006265 A CN 115006265A CN 202210706954 A CN202210706954 A CN 202210706954A CN 115006265 A CN115006265 A CN 115006265A
- Authority
- CN
- China
- Prior art keywords
- gel
- essence
- mask
- base cloth
- cross
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004744 fabric Substances 0.000 claims abstract description 80
- 239000002344 surface layer Substances 0.000 claims abstract description 17
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 239000000499 gel Substances 0.000 claims description 166
- 239000000686 essence Substances 0.000 claims description 125
- 239000003431 cross linking reagent Substances 0.000 claims description 18
- 229920001282 polysaccharide Polymers 0.000 claims description 11
- 239000005017 polysaccharide Substances 0.000 claims description 11
- 150000004804 polysaccharides Chemical class 0.000 claims description 11
- 229920002907 Guar gum Polymers 0.000 claims description 9
- 235000010417 guar gum Nutrition 0.000 claims description 9
- 239000000665 guar gum Substances 0.000 claims description 9
- 229960002154 guar gum Drugs 0.000 claims description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 8
- 239000008273 gelatin Substances 0.000 claims description 8
- 229920000159 gelatin Polymers 0.000 claims description 8
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 8
- 229920001285 xanthan gum Polymers 0.000 claims description 7
- 235000010493 xanthan gum Nutrition 0.000 claims description 7
- 239000000230 xanthan gum Substances 0.000 claims description 7
- 229940082509 xanthan gum Drugs 0.000 claims description 7
- 229920001661 Chitosan Polymers 0.000 claims description 5
- 229910021538 borax Inorganic materials 0.000 claims description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 5
- 235000010418 carrageenan Nutrition 0.000 claims description 5
- 229920001525 carrageenan Polymers 0.000 claims description 5
- 239000000679 carrageenan Substances 0.000 claims description 5
- 229940113118 carrageenan Drugs 0.000 claims description 5
- 238000004132 cross linking Methods 0.000 claims description 5
- 230000003020 moisturizing effect Effects 0.000 claims description 5
- 239000004328 sodium tetraborate Substances 0.000 claims description 5
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 5
- 230000002087 whitening effect Effects 0.000 claims description 5
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 5
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 235000010413 sodium alginate Nutrition 0.000 claims description 4
- 239000000661 sodium alginate Substances 0.000 claims description 4
- 229940005550 sodium alginate Drugs 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 3
- SHKUUQIDMUMQQK-UHFFFAOYSA-N 2-[4-(oxiran-2-ylmethoxy)butoxymethyl]oxirane Chemical compound C1OC1COCCCCOCC1CO1 SHKUUQIDMUMQQK-UHFFFAOYSA-N 0.000 claims description 3
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 230000003266 anti-allergic effect Effects 0.000 claims description 3
- 235000010492 gellan gum Nutrition 0.000 claims description 3
- 239000000216 gellan gum Substances 0.000 claims description 3
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 229960003160 hyaluronic acid Drugs 0.000 claims description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 3
- 244000215068 Acacia senegal Species 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 229920000084 Gum arabic Polymers 0.000 claims description 2
- 235000010489 acacia gum Nutrition 0.000 claims description 2
- 239000000205 acacia gum Substances 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- 230000008859 change Effects 0.000 claims description 2
- 229940045110 chitosan Drugs 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 230000003385 bacteriostatic effect Effects 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 5
- 239000004745 nonwoven fabric Substances 0.000 abstract description 5
- 239000000835 fiber Substances 0.000 abstract description 4
- 238000002791 soaking Methods 0.000 abstract description 4
- 239000002699 waste material Substances 0.000 abstract description 3
- 230000036512 infertility Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 239000000969 carrier Substances 0.000 abstract 1
- 238000003756 stirring Methods 0.000 description 50
- 239000010410 layer Substances 0.000 description 48
- 230000001815 facial effect Effects 0.000 description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 28
- 239000000243 solution Substances 0.000 description 22
- 210000001061 forehead Anatomy 0.000 description 20
- 239000000284 extract Substances 0.000 description 17
- 239000000017 hydrogel Substances 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- -1 for example Substances 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000001804 emulsifying effect Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 229940048053 acrylate Drugs 0.000 description 4
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- 229960000401 tranexamic acid Drugs 0.000 description 4
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 229940101267 panthenol Drugs 0.000 description 3
- 235000020957 pantothenol Nutrition 0.000 description 3
- 239000011619 pantothenol Substances 0.000 description 3
- 239000002985 plastic film Substances 0.000 description 3
- 229920006255 plastic film Polymers 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241001530056 Athelia rolfsii Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000208680 Hamamelis mollis Species 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 235000006679 Mentha X verticillata Nutrition 0.000 description 2
- 235000002899 Mentha suaveolens Nutrition 0.000 description 2
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 240000000249 Morus alba Species 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920004933 Terylene® Polymers 0.000 description 2
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940069078 citric acid / sodium citrate Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002826 coolant Substances 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000010487 meadowfoam seed oil Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- SZUJJDLBXJCDNT-ZCNNSNEGSA-N n-[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]acetamide Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(C)=O SZUJJDLBXJCDNT-ZCNNSNEGSA-N 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940047670 sodium acrylate Drugs 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- 229940118846 witch hazel Drugs 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 1
- WQKLGQXWHKQTPO-UXRZSMILSA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol;2-(2-hydroxypropoxy)propan-1-ol Chemical compound CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CC(O)COC(C)CO.CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WQKLGQXWHKQTPO-UXRZSMILSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 240000004246 Agave americana Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 229920006052 Chinlon® Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 235000005320 Coleus barbatus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 235000008496 Drimys aromatica Nutrition 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 235000012601 Euterpe oleracea Nutrition 0.000 description 1
- 244000207620 Euterpe oleracea Species 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 241000208681 Hamamelis virginiana Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 241000110847 Kochia Species 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 244000178870 Lavandula angustifolia Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 241000226556 Leontopodium alpinum Species 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 235000012854 Litsea cubeba Nutrition 0.000 description 1
- 240000002262 Litsea cubeba Species 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241001529735 Melissa Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 241000131459 Plectranthus barbatus Species 0.000 description 1
- 235000014258 Polygonum bistorta Nutrition 0.000 description 1
- 244000233952 Polygonum bistorta Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 235000010453 Pterocarpus marsupium Nutrition 0.000 description 1
- 240000008976 Pterocarpus marsupium Species 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 241000580938 Sapindus Species 0.000 description 1
- 241000264279 Sargassum fusiforme Species 0.000 description 1
- 241000235346 Schizosaccharomyces Species 0.000 description 1
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 235000019084 Selinum monnieri Nutrition 0.000 description 1
- 244000296102 Selinum monnieri Species 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 241000196252 Ulva Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- RCYWWJBNPIWJMJ-UHFFFAOYSA-N [4-(hexadecanoyloxymethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCCCCCCCCCC RCYWWJBNPIWJMJ-UHFFFAOYSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000003650 acai Nutrition 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940099417 ceramide 2 Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 239000012185 ceresin wax Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 239000002454 curcuma longa l. root extract Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 229920013818 hydroxypropyl guar gum Polymers 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 238000002647 laser therapy Methods 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 229940031722 methyl gluceth-20 Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940078492 ppg-17 Drugs 0.000 description 1
- 229940116393 ppg-20 methyl glucose ether Drugs 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229940064064 purslane extract Drugs 0.000 description 1
- 229940095042 pyridoxine dipalmitate Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 229940104256 sodium taurate Drugs 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000011232 storage material Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000005211 surface analysis Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/737—Galactomannans, e.g. guar; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Cosmetics (AREA)
Abstract
本发明属于化妆品面膜技术领域，具体涉及一种分离式凝胶面膜；本发明的面膜以任选的普通贴式面膜无纺布或纤维织物等作为载体，将面膜、精华液和凝胶分离存放，在使用时，将精华液和凝胶于面膜表层混合，得交联精华凝胶，即现用现制备，凝胶完全吸收精华液，避免了精华液的浪费，保证了凝胶无菌稳定，且不会由于长时间浸泡导致向溶胶转变；凝胶协同精华液贴敷于面部或其他皮肤部位，可以长时间滋养皮肤，并通过调节精华液配方，可以制备各种护肤效果的凝胶面膜，且现用现制备的方式不仅可以制作符合面部的凝胶面膜，还可以改变凝胶形状，制作贴合于其他部位的凝胶敷贴。
Description
技术领域
本发明属于化妆品面膜技术领域，具体涉及一种分离式凝胶面膜。
背景技术
面膜是常用的化妆品精华液的载体形式，用于面部皮肤保养美颜。
由于面膜使用方便且效果显著，在化妆品市场上具有广泛的认可度。传统的面膜通常为贴式型、泥膏型等，此类面膜中通常含有美颜护肤液体，利用其与面部的直接接触，促使面膜中的营养物质深入皮肤角质层，达到保湿、美白、祛痘等目的。
目前，贴型面膜市场占有率为90％以上，最常见的贴型面膜载体主要为无纺布或相关纤维织物。
然而，传统的贴式型面膜存在对精华液吸附量小、保水力不足、皮肤贴合性差等缺点，造成美容活性成分的浪费；关键的，现在贴型面膜一般折叠放置于盛有精华液的袋中，使用时，将面膜拿出，精华液仍有至少一半残留于包装袋中，精华液利用率不高。
水凝胶面膜的出现解决了上述的部分问题，具有较大优势。
然而，相比传统贴式型面膜，水凝胶面膜还有一些缺陷，具体如下：
(1)目前大部分水凝胶面膜为了保证韧性和交联度，通常选用聚合类的水凝胶，然而部分水凝胶成分可能存在有害交联剂，如戊二醛等成分；
(2)聚合反应制备水凝胶可能存留有害单体，例如聚丙烯酸虽然无毒无害，是制备面膜的优选聚合物，但其单体丙烯酸缺对皮肤有腐蚀刺激性，这些交联剂或单体成分可能造成皮肤的潜在危害；
(3)部分水凝胶面膜为了避免上述问题使用天然高分子材料，但是天然高分子材料普遍韧性差，长时间的浸泡溶胀会发生凝胶向溶胶转变的情况，在夏季高温下，这种转变尤为严重，使用时无法取出，或取出后出现开裂，漏洞等情况；
(4)上述两种水凝胶面膜也存在精华液利用率不高的情况，使用时，精华液仍部分残留于包装袋；
(5)水凝胶交联后，由于其良好的隔热性，三维网络结构为细菌提供了良好庇护所，消毒杀菌变得尤为困难，对于直接接触皮肤类化妆品，防止菌落滋生十分重要，此外若水凝胶基质为天然高分子多糖，如羧甲基纤维素钠、黄原胶、卡拉胶、海藻酸钠等等，则会有更大概率出现菌落滋生的情况。
因此，寻找一种精华液利用率高，生物相容性好，稳定安全的凝胶面膜是目前丞待解决的问题。
参考文献：
[1]张小铿,陈乾华,梁国康,等.利用响应面分析法优化聚乙烯醇水凝胶面膜配方.广东化工,2016,43(22):4.
[2]Okan G,Rendon M I.The effects of a high glycerin content hydrogelpremolded mask dressing on post-laser resurfacing wounds.Journal of CutaneousLaser Therapy,2011,13(4):162-165.
[3]Hu J,Liu W,Liu B.Fabric-supported chitosan modified temperatureresponsive PNIPAAm/PU hydrogel and the use thereof in preparation of facialmask:US,US7780979 B2[P].2010.
发明内容
为了解决上述技术问题，本发明提供了一种分离式凝胶面膜，本发明的面膜基布以任选的普通的贴式面膜无纺布或纤维织物作为载体，将面膜基布、精华液和凝胶分离存放，在使用时，将精华液和凝胶于面膜基布表层混合，得交联精华凝胶，即现用现制备，凝胶完全吸收精华液，避免了精华液的浪费，保证了凝胶无菌稳定，且不会由于长时间浸泡导致向溶胶转变；凝胶协同精华液贴敷于面部或其他皮肤部位，可以长时间滋养皮肤，并通过调节精华液配方，可以制备各种护肤效果的凝胶面膜，且现用现制备的方式不仅可以制作符合面部的凝胶面膜，还可以改变凝胶形状，制作贴合于其他部位的凝胶敷贴。
本发明所述凝胶面膜即交联精华凝胶面膜
具体的，本发明的技术方案如下：
一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜、精华液和凝胶分离存放；
所述精华液含有所述凝胶的交联剂；
所述面膜使用时，将精华液和凝胶于面膜基布表层混合，得交联精华凝胶面膜，将交联精华凝胶面膜敷贴于人体表面；其中，“面”泛指人体皮肤表面，包括眼膜、眼贴膜、鼻膜、唇膜、鼻贴膜、手膜、足膜、颈膜等约定俗成术语。
本领域技术人员认为可行的面膜基布均在本发明的保护范围之内。
进一步的，所述凝胶为多糖溶液，多糖溶液粘度≤2000mpa·s。
进一步的，所述凝胶在5～45℃粘度变化≤30％。
进一步的，所述交联精华凝胶为浸吸精华液的三维网状结构凝胶。
优选的，所述多糖溶液的溶质包括但不限于透明质酸和/或透明质酸钠、壳聚糖、海藻酸和/或海藻酸钠、葡聚糖、直链或支链淀粉、硫酸软骨素、肝素、肝素钠、果胶质、瓜尔胶、羟丙基瓜尔胶、羧甲基纤维素钠、卡拉胶、黄原胶、阿拉伯胶、角叉菜多糖、结冷胶、胶原、明胶、琼脂糖、半乳甘露聚糖胶、葡甘露聚糖、刺槐豆胶、普朗尼克、琼脂、藻胶、角叉菜胶、黄原胶、胞外多糖、明胶、甲基纤维素、纤维素、羧甲基纤维素、羟乙基纤维素等；
本本领域技术人员认为可行的天然多糖种类均在本发明的保护范围之内。
优选的，所述交联剂为京尼平、硼砂、季戊四醇，1,4-丁二醇二缩水甘油醚中的一种。
本发明的精华液除交联剂组分外为任意的护肤精华液，鉴于交联剂对精华液pH有略微影响，因此使用缓冲液或pH调节剂将精华液pH调节至最适皮肤外用范围，即5～6.5，所述pH调节剂的实例包括但不限于柠檬酸、柠檬酸钠、精氨酸、三乙醇胺等中的种或多种，本领域技术人员可根据具体需要选择其类型和用量。
本发明还提供一种分离式凝胶面膜在皮肤外用物中的应用。
优选的，上述应用包括但不限于护肤、清洁、消炎、抑菌、调节皮肤温度、抗过敏、保湿补水、美白中的至少一种用途。
与现有技术相比，本发明具有以下有益效果：
1)本发明使精华液与凝胶分离安全稳定，保水性优越，能紧密贴合皮肤，缓慢释放精华液使皮肤充分吸收，不会出现变干情况；
2)相比聚合单体制备法，本发明的分离式凝胶面膜制备条件温和，步骤简单，按使用者的想法自由控制厚度和精华液含量，增加了使用灵活性和趣味性；
3)本发明的凝胶在未使用情况下为粘稠的多糖溶液，使用时交联，便于存放，且灭菌容易，相比交联后的凝胶，省去了生产成本；
4)本发明的分离式凝胶面膜的精华液利用率高，凝胶吸收率高，不会有残留精华液的情况；
5)本发明的分离式凝胶面膜现用现制备，避免了交联后的凝胶由于长时间浸泡溶胀，发生凝胶向溶胶转变的情况。
附图说明
图1为本发明中实施例1或实施例2中的一种分离式凝胶面膜盒盒体和面膜基布整体图；
图2为本发明一种分离式凝胶面膜盒的开盖整体图；
图3为本发明中实施例1或实施例2中的一种分离式凝胶面膜盒盒体和面膜基布分层图；
图4为本发明中实施例1的盒体及限位块整体图；
图5为本发明中实施例1的盒盖正面整体图；
图6本发明中实施例1的盒盖背面整体图；
图7本发明中实施例2的盒盖背面整体图；
图8本发明中实施例2的盒盖正面整体图；
图9本发明中实施例2的卡扣点整体图；
图10本发明中实施例2的搅拌部整体图；
图11本发明中实施例2的带有搅拌棍的搅拌部整体图。
图中：1盒体，2盒盖，3搅拌部，4凝胶盒，5精华液盒，6面膜基布，7限位块，8凹槽，9旋转把手，13卡扣点，21通孔，31搅拌凸起，61贴肤层，62光滑层，63第一启用条，64第二启用条。
具体实施方式
下面通过具体的实施方案叙述本发明。除非特别说明，本发明中所用的技术手段均为本领域技术人员所公知的方法。另外，实施方案应理解为说明性的，而非限制本发明的范围，本发明的实质和范围仅由权利要求书所限定。对于本领域技术人员而言，在不背离本发明实质和范围的前提下，对这些实施方案中的物料成分和用量进行的各种改变或改动也属于本发明的保护范围。
在本发明一些实施例中，提供一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜基布、精华液和凝胶分离存放；所述精华液含有所述凝胶的交联剂；所述面膜使用时，将精华液和凝胶于面膜基布表层混合，得交联精华凝胶面膜。
优选的，面膜基布为任选的普通的贴式面膜无纺布或纤维织物等等作为载体，所选载体符合《化妆品安全技术规范》中对直接接触类产品的规定。
优选的，所述精华液具有护肤、清洁、消炎、抑菌、调节皮肤温度、抗过敏、保湿补水、美白中的至少一种效果。
优选的，所述凝胶为瓜尔胶溶液、羧甲基纤维素钠溶液、黄原胶溶液、海藻酸钠溶液中的一种或其多种混合物。
本发明使精华液与凝胶分离的凝胶基质采用天然生物质多糖，生物相容性优越，安全性高更稳定，保水性优越，能紧密贴合皮肤，缓慢释放精华液使皮肤充分吸收，不会出现变干情况；最关键的，天然生物质多糖本身就为高分子物质，仅需要交联剂于常温下交联即可快速形成三维网络结构凝胶。
在本发明一些实施例中，提供一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜基布、精华液和凝胶分离存放；所述精华液含有所述凝胶的交联剂；所述面膜使用时，将精华液和凝胶于面膜基布表层混合，得交联精华凝胶面膜；所述的面膜基布为符合人脸面部的形状，在面膜基布表层得交联精华凝胶，凝胶粘附于面部内侧，使用时将凝胶侧朝向面部，敷贴于面部，精华液缓慢释放滋养肌肤；
进一步的，所述的面膜基布为医用塑料薄膜，优选PVC、PE、PP；本领域人员认为可行的其他医用塑料薄膜也在本发明保护范围之内。
优选的，将凝胶侧朝向面部，敷贴于面部后，将面膜基布(即医用塑料薄膜)揭下，面部敷贴一层交联精华凝胶，进一步的，使用完后，直接清水洗净即可。
在本发明一些实施例中，提供一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜基布、精华液和凝胶分离存放；所述精华液含有所述凝胶的交联剂；所述面膜基布为贴合其他皮肤部位形状的敷贴，包括但不限于额头敷贴、手臂敷贴、大腿敷贴、小腹敷贴、手/脚部敷贴等等；
优选的，所述面膜基布为方形适合额头的额头敷贴；
所述精华液成分包括但不限于水、抑菌剂、清凉剂、保湿剂、交联剂、抗冻剂；
优选的，所述清凉剂为乙醇；本领域技术人员认为可行的其他用于散热清凉的皮肤外用成分也在本发明保护范围之内。
优选的，所述抗冻剂为甘油；本领域技术人员认为可行的其他用于抗冻的无毒无害成分也在本发明保护范围之内。
具体的，使用时将精华液与凝胶于额头敷贴表层混合，常温搅拌交联，得到不溶于水的交联三维网络水凝胶额头敷贴；
优选的，将所述不溶于水的交联三维网络凝胶额头敷贴于0℃～-10℃冷冻1～15min；
使用时，将不溶于水的交联三维网络凝胶额头敷贴，贴于发热者额头，起到降温散热的作用。
在本发明一些实施例中，提供一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜基布、精华液和凝胶分离存放；所述精华液含有所述凝胶的交联剂；所述精华液包括以下重量比的组分：1,4-丁二醇二缩水甘油醚0.2～0.3％、保湿剂5～12％、美白剂2～9％、皮肤调理剂0.1～0.5％、乳化剂0.1～1％、润肤剂3～6％、天然提取物、余量为水添加至100％；
天然提取物提取至少选自下列至少一种原料，包括但不限于：芦荟、绿茶、人参、红参、焦木酸、松针、银杏叶、蜂胶、桑叶、蚕、蜗牛粘液、卡卡杜李、卡姆果、阿萨伊棕榈、角鲨烷、鱼子酱、椰菜、蓝莓、金缕梅、金虎尾、小球藻、山竹果、番石榴、日本山樱、胡萝卜、咖啡豆、金缕梅、螺旋藻、鲑鱼籽、山胡椒、巨藻、海带、马齿苋、石莼、琼脂、桑树根、覆盆子、野生浆果、羊栖菜、马尾草、火绒草、甘菊、薰衣草、薄荷、桉树、蜜蜂花、牛至、茶树、黄芩、鱼腥草、沙棘和香橼。
所述保湿剂的实例包括但不限于甘油、海藻糖、泛醇、内二醇、1,2-戊二醇、甘露醇、甘油聚醚-26、鼠李糖、棉子糖、赤藓醇、聚乙二醇-8、聚乙二醇-32、甲基葡糖醇聚醚-10、甲基葡糖醇聚醚-20、PEG/PPG-17/6共聚物、聚谷氨酸钠、木糖醇、尿素、水解小核菌胶、聚谷氨酸钠、甘油葡糖苷、PPG-10甲基葡糖醚、出芽短梗酶多糖、银耳多糖、PPG-20甲基葡糖醚等中的一种或多种。
所述皮肤调理剂可用于保湿、抗皱、祛斑、祛痘、控油等功效。其实例包括但不限于植物甾醇/辛基十二醇月桂酰谷氨酸酯、姜黄根提取物、神经酰胺2、神经酰胺3、水解透明质酸钠、乙酰植物鞘氨醇、胆甾醇、曲酸、抗坏血酸、抗坏血酸葡糖苷、尿囊素、白桦树皮提取物、氢化卵磷脂、熊果苷、传明酸(凝血酸)、烟酰胺、乙酰植物鞘氨醇、白藜芦醇、花榈木树皮提取物、毛喉鞘蕊花根提取物、红没药醇、抗坏血酸四异棕榈酸酯、胡椒籽提取物、泛醌、吡哆素二棕榈酸酯、吡哆素二辛酸酯、视黄醇棕榈酸酯、生育酚乙酸酯、燕麦仁提取物等中的一种或多种。
所述润肤剂的实例包括但不限于甘油三(乙基己酸)酯、辛酸/癸酸甘油三酯、葡萄籽油、白池花籽油、牛油果树果脂、鲸蜡醇、聚二甲基硅氧烷，季戊四醇四(乙基己酸)酯、橄榄油、鳄梨油、玉米油、碳酸二辛酯、胡莫柳酯、角蜜烷、硬脂醇、肉豆蔻酸异丙酯、肉豆蔻醇、氢化聚癸烯、毛瑞榈果油、向日葵籽油、异十六烷、霍霍巴油、羊毛脂、石蜡、微品蜡、蜂蜡等中的一种或多种。
在本发明一些实施例中，提供一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜基布、精华液和凝胶分离存放；所述精华液含有所述凝胶的交联剂；
所述精华液包括药物活性成分；所述药物话性成分是本领域已知的用于缓解皮肤瘙痒的成分，其实例包括但不限于苦参提取物、丹皮酚、芳樟醇、桉油素、冰片，硫磺、蝉蜕、蛇床子提取物、地肤子提取物、拳参提取物、紫苏提取物、炉甘石、无患子皂苷、马齿苋提取物、甘草酸铵等。
在本发明一些实施例中，提供一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜基布、精华液和凝胶分离存放；所述精华液含有所述凝胶的交联剂；
所述精华液包括以下重量比的组分：四硼酸钠0.1～0.2％、丁二醇5～10％、棕榈酸乙基己酯1～5％、辛酸/癸酸甘油三酯2～5％、甘油2～4％、聚甘油-101～5％、异王酸乙基己酯1～5％、聚二甲基硅氧烷12％、鲸蜡硬脂醇0.5～2％、硬脂醇聚醚-2 0.5～2％、丙烯酸(酯)类/丙烯酰胺共聚物0.10～8％、甜菜碱0.21％、乳酸杆菌发酵产物提取物0.31％、北美金缕梅提取物0.3～1％、蜂王浆提取物0.3～1％、生育酚乙酸酯0.1～0.5％、卡波姆0.10～5％、EDTA-2Na 0.010～0.3％、三乙醇胺0.05～0.3％、防腐剂0.1～4％、香精0.01～2％，余量为水添加至100％。
在本发明一些实施例中，提供一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜基布、精华液和凝胶分离存放；所述精华液含有所述凝胶的交联剂；
所述精华液包括以下重量百分比组分：蓄冷剂0.5～2％、增稠剂1～10％、保湿剂5～6％、防冻剂0.5～1％、调和剂0.1～0.9％、清凉舒适精油0.01～0.5％。
所述增稠剂的实例包括但不限于羟乙基纤维素、羟丙基纤维素、卡波姆、黄原胶、阿拉伯胶、聚乙二醇-14M、聚乙二醇-90M、琥珀酰聚糖、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物等中的一种或多种。本领域技术人员可根据需要具体选择其类型和用量。
优选的，所述精华液包括以下重量百分比组分：丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物0.5％、甘油1.5％、丙二醇0.5％、薰衣草油0.2％。
优选的，所述清凉舒适精油包括但不限于薄荷精油、玫瑰油、橙花油、柠檬油等。
以上本发明的精华液制备可以通过本领域已知的任何合适的方法制备。例如，可使用本领域中常用的溶解槽、乳化锅、分散器、输送泵等容器来制备。制备时，先将水溶性物质投入水相溶解釜，将油溶性物质投入油相溶解釜，分别将两个釜的温度加热至80℃左右，其中对于易结块的原料，可先用分散器将其预分散。待溶解完成后将油相和水相输送至乳化锅中，均质乳化约5～15分钟。乳化完成后将料体温度降至常温，任选加入香精、防腐剂等，并视需要调节产物的pH，相关检测指标都合格后方可灌装出货。
以上制备方法可根据剂型要求进行删减或调整。可根据需要制备液体、乳液等剂型的药物组合物或者化妆品组合物，其中所述精华液可以是化妆水、喷雾、乳液、爽肤水等形式。
本发明还可以通过一种分离式凝胶面膜盒来实现，所述分离式凝胶面膜盒包括盒体1、盒盖2、搅拌装置、凝胶盒4、精华液盒5、面膜基布6；所述盒体1内部放置凝胶盒4、精华液盒5和面膜基布6，盒体1开口端盖有盒盖2，所述盒盖2连接有搅拌装置；面膜基布6平铺于盒体1底部，凝胶盒4和精华液盒5放置于面膜基布6上层；所述凝胶盒4、精华液盒5分别存放凝胶、精华液，面膜基布6为本发明所述的面膜基布。
所述凝胶盒4、精华液盒5可以为盒体结构，也可以为袋装。
所述盒盖2连接有搅拌装置，连接方式为固定连接、可拆卸式连接中的一种。
优选的，搅拌装置为搅拌部3或搅拌突起31。
优选的，所述盒体1为顶部开口圆柱体，其内腔足够容纳凝胶盒4和精华液盒5平躺放置，其横截面面积大于面膜基布6横截面面积，盒盖2为略大于盒体1横截面直径的圆形片；所述面膜基布6完全展开，平铺于盒体1底部，面膜基布6上方放置凝胶盒4和精华液盒5，面膜基布6贴近皮肤一侧朝向盒体1开口端，盒盖2扣于盒体1开口处。
使用时，打开盒盖2，将凝胶盒4和精华液盒5取出，摇晃混匀，先将凝胶均匀倒于面膜表层，凝胶的粘度≤2000mpa·s，因此在均匀的倒置在面膜表层后可短时间流平，再将精华液均匀倒于凝胶层之上，使用盒盖2上的搅拌部3简单搅拌使两者混匀，静置0.5～3min，得到交联精华凝胶面膜，交联精华凝胶经测试，玻璃表层剥离粘附力为15±3.8N，因此交联精华凝胶面膜垂直于地面交联精华凝胶不掉落，将带有交联精华凝胶的面膜基布6取出，敷于脸部使用。优选的，所述盒体1内部侧壁有若干相对横切面直径的限位块7，所述盒盖2朝向盒体1一面固定连接有若干搅拌凸起31，朝外一面固定连接有旋转把手9，盒盖2盖于限位块之上，其边缘有对应限位块的凹槽8，所述凹槽8与限位块7重合时，盒盖2不受限位块限位块7限制，下沉至盒体1底部，通过旋转把手9，带动搅拌凸起31转动，实现对精华液和凝胶的搅拌。
优选的，搅拌部3为四扇叶子状，中心有圆形卡槽12，盒体2中间有对应搅拌部3四扇叶子状的通孔21，搅拌部3以通孔21嵌合在盒盖2中间，盒盖2通过通孔21侧壁的卡扣点13连接搅拌部3，卡扣点13为弹性体材料，优选PVC或PP塑料，卡扣点13与搅拌部3的叶片侧边过盈配合，此外，所述盒体1内部还放置搅拌棍11，搅拌时，所述搅拌棍11连接至圆形卡槽12，向下按压搅拌部3使其与盒盖2脱离，通过转动搅拌棍11实现搅拌部3的转动，进而搅拌精华液和凝胶，得到交联精华凝胶。
优选的，所述面膜基布6为双层结构，平铺于盒体1底部，贴于盒体1底部的一侧为光滑层61，光滑层61上层紧密贴合贴肤层62，所述光滑层61有延伸至盒体1内壁的第一启用条63和第二启用条64，第一启用条63和第二启用条64于光滑层61额头双侧对称分布，除延伸出来的第一启用条63和第二启用条64外，光滑层61与贴肤层62形状重合；
使用时，贴肤层62表层搅拌得到交联精华凝胶，使用者双手分别拿第一启用条63和第二启用条64，将面膜基布6同交联精华凝胶敷于脸部，然后揭下光滑层61，通过这种方式，方便取用面膜，避免了用手直接接触面膜造成面膜损坏或是引入细菌的风险。
实施例1
一种分离式凝胶面膜，由面膜基布、精华液和凝胶组成，面膜基布为无纺布材质，厚度0.3mm；
精华液的组分为：丁二醇2～5％、甘油10％、海藻糖1％、四硼酸钠0.2％、丙烯酸钠1.0％、丙烯酰二甲基牛磺酸钠共聚物0.85％、柠檬酸\柠檬酸钠缓冲液，加水至100％。
精华液制备方法为：先将丁二醇、甘油、丙烯酸钠、海藻糖、四硼酸钠、丙烯酰二甲基牛磺酸钠投入水相溶解釜加热至80℃，待溶解完成后输送至乳化锅中，均质乳化15分钟，乳化完成后将料体温度降至40℃，加入龙舌兰根茎提取物，并柠檬酸\柠檬酸钠缓冲液调节产物的pH至6.12。
凝胶为瓜尔胶溶液，粘度为1433mpa·s；
瓜尔胶溶液的制备方法为：将100mL蒸馏水于500mL烧杯中溶解，加磁子于磁力搅拌器上搅拌，加入2g化妆品级瓜尔胶，搅拌2min，得到淡黄色粘稠溶液。
将15mL精华液和10mL瓜尔胶溶液分别存放至20mL规格精华液盒和15mL规格的凝胶盒中，备用；
面膜基布6为双层结构，规格为标准脸型面膜基布，平铺于盒体1底部，贴于盒体1底部的一侧为光滑层61，光滑层61上层紧密贴合贴肤层62，所述光滑层61有延伸至盒体1内壁的第一启用条63和第二启用条64，第一启用条63和第二启用条64于光滑层61额头双侧对称分布，除延伸出来的第一启用条63和第二启用条64外，光滑层61与贴肤层62形状重合，贴肤层62上层放置20mL规格精华液盒和15mL规格的凝胶盒；
盒体1为顶部开口圆柱体，直径为210mm，盒高10mm，其横截面面积大于面膜基布6横截面面积，盒盖2为略大于盒体1横截面直径的圆形片；面膜基布6完全展开，平铺于盒体1底部，面膜基布6上方放置凝胶盒4和精华液盒5，面膜基布6贴近皮肤一侧朝向盒体1开口端。
盒体1内部侧壁有四块限位块7，相对盒体1圆心平均分布，盒盖2朝向盒体1一面固定连接有若干搅拌突起31，盒盖2边缘有对应限位块的凹槽8，朝外一面固定连接有旋转把手9，盒盖2盖于限位块之上，密封盒体1，得到分离式凝胶面膜盒。
使用时，将瓜尔胶溶液全部均匀倒于贴肤层62表层，缓慢加入精华液，将盒盖2的凹槽8与限位块7重合，盒盖2不受限位块7限制，下沉至盒体1底部，通过旋转把手9，带动搅拌凸起31转动，搅拌30s使凝胶交联，在贴肤层62表层得到厚度为一层约0.5mm厚度的凝胶，交联精华凝胶与贴肤层62表层黏附，垂直状态下不掉落；使用者双手分别拿第一启用条63和第二启用条64，将面膜基布6同交联精华凝胶敷于脸部，然后揭下光滑层61，敷于脸部20min，揭下。
上述分离式凝胶面膜盒，除面膜6外，其他装置的材质均为PP塑料。
经测试，本实施例的一种分离式凝胶面膜符合QBT2872-2017面膜标准。
实施例2
一种分离式凝胶面膜，由面膜基布、精华液和凝胶组成，面膜基布为涤纶材质，厚度0.5mm；
所述“％”为重量百分比。
精华液的组分为：丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物0.11％、聚甘油-3 2％、MD-100(四羟丙基乙二胺)0.075％、对羟基苯乙酮0.5％、1,2-己二醇0.5％、水解小核菌胶0.03％、甘油3％、泛醇1％、角鲨烷1％、白池花籽油0.25％、二裂酵母发酵提取物1％、传明酸0.02％；加水至100％。
(1)水相：将纯净水、丙烯酸(酯)类/C10-30烷醇丙烯酸酯交联聚合物、聚甘油-3、MD-100(四羟丙基乙二胺)、对羟基苯乙酮、1,2-己二醇、水解小核菌胶、甘油、泛醇加热至85℃，搅拌均匀，冷却；
(2)油相：将角鲨烷、白池花籽油加热至80℃，搅拌均匀；
(3)将二裂酵母发酵提取物、传明酸混合均匀，缓慢加入到步骤(1)中的在45℃的混合物中，搅拌120分钟；
(4)将步骤(2)中的混合物降温至45℃，同加入到步骤(3)中的混合物中，搅拌均匀，冷却，并柠檬酸\柠檬酸钠缓冲液调节产物的pH至6.2。
凝胶为透明质酸钠溶液，粘度为1523mpa·s；
透明质酸钠溶液的制备方法为：将100mL蒸馏水于500mL烧杯中溶解，40℃加磁子于磁力搅拌器上搅拌，加入1g透明质酸钠和0.5g透明质酸，搅拌2min，得到透明粘稠溶液。
将15mL精华液和10mL透明质酸钠溶液分别存放至20mL规格精华液盒和15mL规格的凝胶盒中，备用；
面膜基布6为双层结构，规格为标准脸型面膜基布，平铺于盒体1底部，贴于盒体1底部的一侧为光滑层61，光滑层61上层紧密贴合贴肤层62，所述光滑层61有延伸至盒体1内壁的第一启用条63和第二启用条64，第一启用条63和第二启用条64于光滑层61额头双侧对称分布，除延伸出来的第一启用条63和第二启用条64外，光滑层61与贴肤层62形状重合，贴肤层62上层放置上述的20mL规格精华液盒和15mL规格的凝胶盒；
盒体1为顶部开口圆柱体，直径为210mm，盒高10mm，其横截面面积大于面膜基布6横截面面积，盒盖2为略大于盒体1横截面直径的圆形片；面膜基布6完全展开，平铺于盒体1底部，面膜基布6上方放置凝胶盒4和精华液盒5，面膜基布6贴近皮肤一侧朝向盒体1开口端。
搅拌部3为四扇叶子状，中心有圆形卡槽12，盒体2中间有对应搅拌部3四扇叶子状的通孔21，搅拌部3以通孔21嵌合在盒盖2中间，盒盖2通过通孔21侧壁的卡扣点13连接搅拌部3，卡扣点13为PVC塑料，卡扣点13与搅拌部3的叶片侧边过盈配合，此外，盒体1内部还放置搅拌棍11，使用时，将透明质酸钠溶液全部均匀倒于贴肤层62表层，缓慢加入精华液，将搅拌棍11连接至圆形卡槽12，向下按压搅拌部3使其与盒盖2脱离，通过转动搅拌棍11实现搅拌部3的转动，搅拌2min使凝胶交联，在贴肤层62表层得到厚度为一层约0.5mm厚度的凝胶，交联精华凝胶与贴肤层62表层黏附，垂直状态下不掉落；使用者双手分别拿第一启用条63和第二启用条64，将面膜基布6敷于脸部，然后揭下光滑层61，敷于脸部20min，揭下。
上述分离式凝胶盒，除面膜6和卡扣点13外，其他装置的材质均为PP塑料。
经测试，本实施例的一种分离式凝胶面膜符合QBT2872-2017面膜标准。
实施例3
一种分离式凝胶额头敷贴，包括额头敷贴、精华液和凝胶，额头敷贴、精华液和凝胶分离存放；所述精华液含有所述凝胶的交联剂；
额头敷贴为80mm×150mm方形涤纶织物，贴肤侧有密集带状凹形纹路。
所述精华液为以下重量份数组分：京尼平醋酸水溶液1％，β-葡聚糖0.05％、黄原胶0.1％、甘油3％、1,2-戊二醇1％、丁二醇1％、薄荷精油0.2％、乙醇1.5％；
凝胶为壳聚糖-明胶混合溶液，壳聚糖分子量为2×105，粘度为1827mpa·s；
壳聚糖-明胶混合溶液的制备方法为：1g壳聚糖，2g明胶溶于100mL超纯水，常温加磁子于磁力搅拌器上搅拌，得到透明粘稠溶液。
交联精华凝胶的制作方式同实施例1；
不同之处在于，不使用分离式凝胶面膜盒，直接将额头敷贴平铺，先将壳聚糖-明胶混合溶液均匀倒至额头敷贴贴肤侧，再将精华液均匀倒至壳聚糖-明胶混合溶液中，静置，得到不溶于水的交联三维网络凝胶额头敷贴。
使用时，不溶于水的交联三维网络凝胶额头敷贴，贴于发热者额头，起到降温散热的作用。
经测试，本实施例的一种分离式凝胶面膜符合QBT2872-2017面膜标准。
Claims (9)
1.一种分离式凝胶面膜，包括面膜基布、精华液和凝胶，所述面膜基布、精华液和凝胶分离存放；
所述精华液含有能够交联所述凝胶的交联剂；
所述面膜使用时，将精华液和凝胶于面膜基布表层混合，得到交联精华凝胶面膜。
2.如权利要求1所述的一种分离式凝胶面膜，其特征在于，所述凝胶为多糖溶液，多糖溶液粘度≤2000mpa·s。
3.如权利要求1或2所述的一种分离式凝胶面膜，其特征在于，所述凝胶在5～45℃粘度变化≤30％。
4.如权利要求1所述的一种分离式凝胶面膜，其特征在于，混合后的精华液和凝胶为浸吸精华液的三维网状结构凝胶。
5.如权利要求2所述的一种分离式凝胶面膜，其特征在于，所述多糖溶液的溶质为透明质酸和/或透明质酸钠、壳聚糖、海藻酸和/或海藻酸钠、瓜尔胶、羧甲基纤维素钠、卡拉胶、黄原胶、阿拉伯胶、结冷胶、胶原、明胶中的至少一种。
6.如权利要求1所述的一种分离式凝胶面膜，其特征在于，所述交联剂为京尼平、硼砂、季戊四醇、1,4-丁二醇二缩水甘油醚中的一种。
7.如权利要求1所述的一种分离式凝胶面膜，其特征在于，所述精华液由pH调节剂调节pH至5.0～6.0。
8.权利要求1或2所述的一种分离式凝胶面膜在皮肤外用物中的应用。
9.如权利要求8所述的应用，其特征在于，包括修护、清洁、舒缓、抑菌、调节皮肤温度、抗过敏、保湿补水、美白中的至少一种用途。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210706954.9A CN115006265A (zh) | 2022-06-21 | 2022-06-21 | 一种分离式凝胶面膜 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210706954.9A CN115006265A (zh) | 2022-06-21 | 2022-06-21 | 一种分离式凝胶面膜 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115006265A true CN115006265A (zh) | 2022-09-06 |
Family
ID=83077131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210706954.9A Pending CN115006265A (zh) | 2022-06-21 | 2022-06-21 | 一种分离式凝胶面膜 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115006265A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116509755A (zh) * | 2023-07-04 | 2023-08-01 | 成都普什制药有限公司 | 一种次抛分离式面膜及其含有的面膜精华液 |
| CN116695339A (zh) * | 2023-07-10 | 2023-09-05 | 中科纺织研究院（青岛）有限公司 | 一种含植物活性成分的pp纺粘无纺布及其制备方法 |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200735893A (en) * | 2006-03-17 | 2007-10-01 | su-hua Li | Natural hydrogel beauty and skin care patch |
| WO2014014139A1 (ko) * | 2012-07-18 | 2014-01-23 | Shin Hyunwoo | 2액형 타입 미용용 팩류 및 패취류 조성물 |
| TW201600113A (zh) * | 2014-06-24 | 2016-01-01 | 萬能學校財團法人萬能科技大學 | 三劑型面膜 |
| KR20160019306A (ko) * | 2014-08-11 | 2016-02-19 | 주식회사 래디안 | 이중 하이드로겔 마스크팩의 제조방법 |
| TWM518498U (zh) * | 2015-12-07 | 2016-03-11 | Maxgut Biochemical Co Ltd | 高分子凝膠面膜 |
| CN109481341A (zh) * | 2018-12-05 | 2019-03-19 | 杞源堂（宁夏）生物科技有限公司 | 一种枸杞滋养的晒后修复的凝胶面膜及其制备方法 |
| CN210384441U (zh) * | 2019-04-26 | 2020-04-24 | 碧昂吉美生物科技有限公司 | 一种具备复合层的芦荟面膜基布及其面膜 |
| WO2020111875A1 (ko) * | 2018-11-30 | 2020-06-04 | (주)아모레퍼시픽 | 하이드로겔 마스크 조성물, 이를 이용하여 제조된 하이드로겔 마스크 및 그 제조방법 |
| CN211686347U (zh) * | 2019-10-29 | 2020-10-16 | 天津珂芬迪斯生物医药科技有限公司 | 一种面膜与精华液分离的面膜包装袋 |
| CN112121032A (zh) * | 2020-10-30 | 2020-12-25 | 山东华熙海御生物医药有限公司 | 一种皮肤护理用水凝胶贴及其制备方法 |
| CN112641638A (zh) * | 2020-12-24 | 2021-04-13 | 上海添美信息技术有限公司 | 一种自响应水凝胶活性面膜及其制备方法 |
-
2022
- 2022-06-21 CN CN202210706954.9A patent/CN115006265A/zh active Pending
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200735893A (en) * | 2006-03-17 | 2007-10-01 | su-hua Li | Natural hydrogel beauty and skin care patch |
| WO2014014139A1 (ko) * | 2012-07-18 | 2014-01-23 | Shin Hyunwoo | 2액형 타입 미용용 팩류 및 패취류 조성물 |
| TW201600113A (zh) * | 2014-06-24 | 2016-01-01 | 萬能學校財團法人萬能科技大學 | 三劑型面膜 |
| KR20160019306A (ko) * | 2014-08-11 | 2016-02-19 | 주식회사 래디안 | 이중 하이드로겔 마스크팩의 제조방법 |
| TWM518498U (zh) * | 2015-12-07 | 2016-03-11 | Maxgut Biochemical Co Ltd | 高分子凝膠面膜 |
| WO2020111875A1 (ko) * | 2018-11-30 | 2020-06-04 | (주)아모레퍼시픽 | 하이드로겔 마스크 조성물, 이를 이용하여 제조된 하이드로겔 마스크 및 그 제조방법 |
| CN109481341A (zh) * | 2018-12-05 | 2019-03-19 | 杞源堂（宁夏）生物科技有限公司 | 一种枸杞滋养的晒后修复的凝胶面膜及其制备方法 |
| CN210384441U (zh) * | 2019-04-26 | 2020-04-24 | 碧昂吉美生物科技有限公司 | 一种具备复合层的芦荟面膜基布及其面膜 |
| CN211686347U (zh) * | 2019-10-29 | 2020-10-16 | 天津珂芬迪斯生物医药科技有限公司 | 一种面膜与精华液分离的面膜包装袋 |
| CN112121032A (zh) * | 2020-10-30 | 2020-12-25 | 山东华熙海御生物医药有限公司 | 一种皮肤护理用水凝胶贴及其制备方法 |
| CN112641638A (zh) * | 2020-12-24 | 2021-04-13 | 上海添美信息技术有限公司 | 一种自响应水凝胶活性面膜及其制备方法 |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116509755A (zh) * | 2023-07-04 | 2023-08-01 | 成都普什制药有限公司 | 一种次抛分离式面膜及其含有的面膜精华液 |
| CN116509755B (zh) * | 2023-07-04 | 2023-09-05 | 成都普什制药有限公司 | 一种次抛分离式面膜及其含有的面膜精华液 |
| CN116695339A (zh) * | 2023-07-10 | 2023-09-05 | 中科纺织研究院（青岛）有限公司 | 一种含植物活性成分的pp纺粘无纺布及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115006265A (zh) | 一种分离式凝胶面膜 | |
| KR102055150B1 (ko) | 경피 흡수 능력이 증진된 마스크팩용 세포간지질 모사체 조성물, 이의 제조방법 및 이를 함유하는 하이드로겔 마스크팩 | |
| CN101889958B (zh) | 冻干组合物 | |
| JP4959328B2 (ja) | 温度感応性状態変化ハイドロゲル組成物及びその製造方法 | |
| CN106137786B (zh) | 一种透明质酸抗衰组合物及其制备方法和应用 | |
| EP2921164A1 (en) | Sticky hydrogel cosmetic composition | |
| CN101801332B (zh) | 用于活体的粘着性凝胶片和包含其的片状化妆品 | |
| CN102058512A (zh) | 局部皮肤护理制剂 | |
| CN103209677B (zh) | 皮肤增湿剂和老化抑制配制剂 | |
| JPH07500593A (ja) | 非イオン性ポリアクリルアミド誘導体を含有した低ｐＨ水性化粧品ゲル | |
| WO2010143196A1 (en) | Novel synergistic transparent / translucent hydrogel composition; method of preparing it and a sheet / film made thereform | |
| KR101768710B1 (ko) | 주름개선 기능성을 갖는 속눈썹 연장시술용 패치 제조방법 | |
| CN103857412A (zh) | 乳化水凝胶组合物及其生产方法 | |
| KR20170142805A (ko) | 피부 마스크팩 및 이의 사용방법 | |
| CN104887561A (zh) | 一种医用海洋生物成分的水凝胶护眼贴 | |
| CN108478453A (zh) | 玻尿酸面膜液及其制作方法 | |
| CN105496809A (zh) | 肉苁蓉苯乙醇总苷微乳凝胶剂及其制备方法 | |
| JP2008285461A (ja) | 生体用粘着ゲルシートおよびそれを含むシート状化粧料 | |
| TW200920414A (en) | Gel sheet and sheet-like cosmetic material using the same | |
| CN106852815A (zh) | 一种细致毛孔面贴膜 | |
| CN109010263A (zh) | 一种超温度变化的可逆性液态-凝胶转换反向智能水凝胶及其制备方法 | |
| KR20230049560A (ko) | 천연물 유래의 피부개선용 화장조성물 | |
| CN103211753B (zh) | 一种凝胶剂基质 | |
| KR20180069487A (ko) | 스피큘을 포함하는 하이드로겔 조성물 및 이의 용도 | |
| CN1864753A (zh) | 贴剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |